The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy (Q61905658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Gian Paolo Dagrada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Brian A. Walker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Christopher P Wardell

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Gareth J Morgan

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Laura Chiecchio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

David Gonzalez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Fiona M Ross

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

William J Tapper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Zoe J Konn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sarah L Hockley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Walter M Gregory

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Anthony Child

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Graham H Jackson

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Faith E Davies

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

NCRI Haematology Oncology Studies Group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

Genes, Chromosomes and Cancer

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

765-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

13 February 2020

cites work

1 reference

7 January 2021

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

7 January 2021

Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

1 reference

7 January 2021

p53 and its isoforms in cancer

1 reference

7 January 2021

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

1 reference

7 January 2021

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

1 reference

7 January 2021

Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma

1 reference

7 January 2021

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

1 reference

7 January 2021

Clinical significance of TP53 mutation in myeloma

1 reference

7 January 2021

Clinical and biologic implications of recurrent genomic aberrations in myeloma

1 reference

7 January 2021

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

1 reference

7 January 2021

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial

1 reference

7 January 2021

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials

1 reference

7 January 2021

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

1 reference

7 January 2021

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).

1 reference

7 January 2021

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

1 reference

7 January 2021

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

1 reference

7 January 2021

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

1 reference

7 January 2021

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation

1 reference

7 January 2021

p53 gene mutations in multiple myeloma.

1 reference

7 January 2021

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.

1 reference

7 January 2021

TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3

1 reference

7 January 2021

Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma

1 reference

7 January 2021

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma

1 reference

7 January 2021

TP53 mutation and survival in chronic lymphocytic leukemia

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21961181%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference